Approaches to
treatment

Current gene and stem cell therapies are in early phase clinical trials for a small number of conditions. The aim of these studies is to determine the relative safety of these novel therapies and indicate any potential benefit for vision. Further studies will be needed, but the current trials will provide important insights that will help design even better therapies and expand the range of conditions they can be applied to.